Cart
0

DNA Diagnostics Market by Product Type (Instruments, Reagents, Service & Software), Technology (PCR, Microarray, In-situ Hybridization, Sequencing Technology, Mass Spectrometry), Application (Infectious Disease (Hepatitis B Virus, Hepatitis C Virus, HIV, TB, CT/NG, HPV, MRSA), Myogenic Disorder, Prenatal Diagnostics, Pre-implantation Diagnostics) - Global Opportunity Analysis and Industry Forecast, 2013 - 2020

Get 20% Free Customization In This Report
LI_14298
Pages: 170
Aug 2014 | 5989 Views
 
Author's : Debbie Shields & Sharayu Dhabale
Tables: 56
Charts: 42
 

DNA Diagnostics Market Overview:

Global DNA diagnostics market is expected to garner $19 billion by 2020, registering a CAGR of 9.8% during the forecast period 2014-2020.

DNA diagnostics is a cutting edge method which is set to revolutionize the field of medical diagnostics. This technique enables medical professionals to identify various diseases, such as cancer, infectious diseases, and myogenic disorders, and to determine the appropriate treatment for the same.

It is also used for clinical diagnostic confirmation and in prenatal diagnostics. The concept of DNA diagnostics has evolved via the breakthrough human genome project that resulted in the discovery of various disease-causing agents. Technological development has played a major role in improving DNA diagnostic platforms and techniques.

Some of the significant technologies which incorporate DNA diagnostics include polymerase chain reaction (PCR), microarray techniques, sequencing technology and mass spectrometry; these technologies are used for sample preparation, DNA isolation etc. Technological developments, which have led to improvements in these methodologies, drive the growth of the DNA diagnostics market. The use of DNA diagnostic methods in prenatal diagnostics and clinical confirmation has also boosted market growth. The DNA diagnostics market is expected to experience a growth spurt in the foreseeable future. Innovations in product design and technology have prompted doctors and researchers to shift their focus from traditional diagnostic methods to personalized medicines. The increased adoption of the personalized medicines approach would positively impact the DNA diagnostics market in the foreseeable future. Next generation sequencing is a powerful tool for decoding a number of human diseases, including various forms of cancer. Next generation sequencing reduces the cost of sequencing and increases the throughput. The optimization of sequencing technology could greatly impact the DNA diagnostics market.

The report breaks the market into segments based on product type, technology, application, end users and geography. Based on product types, the market is segmented into instruments, reagents and service & software. The instruments segment holds the dominant share in the market, due to improved healthcare facilities, availability of user-friendly instruments, its competitive cost structure, reliability, size and the growing demand for it in the DNA diagnostics market. However, the service & software segment is expected to grow at a steady rate in the near future due to technological advancements and the incorporation of information technology in the DNA diagnostics market. There are several technologies used in the DNA diagnostics market; these include PCR, mass spectrometry, sequencing technology, in-situ hybridization and microarrays. PCR holds the dominant share due to its frequent usage in diagnostic procedures such as sample preparation, separation and isolation of DNA from collected samples. The DNA diagnostics market is also segmented based on its application in various diseases such as oncology, infectious diseases and myogenic disorders. The oncology segment leads the market and is followed by infectious diseases due to the rising incidence of these diseases and growing elderly population. In terms of geography, the market is segmented into North America, Asia Pacific, Europe and LAMEA. North America holds the dominant share in the market due to the increased adoption of the DNA diagnostics technology and the high prevalence of chronic and infectious diseases. Companies profiled in the report include Roche Diagnostics, Bayer Diagnostic, Sysmex, Abbott laboratories, Gene-probe Inc., Cephide, Illumina, Inc., Bio-Rad Laboratories, Thermo Fisher Scientific, Johnson and Johnson, and Novartis.

Global DNA Diagnostics Market

Get more information on this report : Request Sample Pages

KEY BENEFITS

  • An in-depth analysis of various regions would provide a clear understanding of current and future trends so that companies can make region specific plans
  • The report studies the application of next generation sequencing technology and biotechnology and their impact on the DNA diagnostics market
  • A comprehensive analysis of the factors that drive and restrict the growth of the DNA diagnostics market is provided
  • Key regulatory guidelines in various regions which impact the DNA diagnostics market are critically examined
  • A quantitative analysis of the current market and estimations through 2013-2020 are provided to showcase the financial caliber of the DNA diagnostics market
  • Detailed analysis of the Asia-pacific region provides insights that would enable companies to plan their business move strategically
  • Value chain analysis in the report gives a clear understanding of the roles of the stakeholders involved in the supply chain of the DNA diagnostics market

MARKET SEGMENTATION:

The DNA diagnostics market is segmented based on product type, technology, application, end users and geography

MARKET BY PRODUCT TYPE

  • Instruments
  • Reagents
  • Service & Software

MARKET BY TECHNOLOGY

  • PCR
  • Microarray
  • In-situ Hybridization
  • Sequencing Technology
  • Mass Spectrometry
  • Others

MARKET BY APPLICATION

  • Oncology
    • Prostate Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Others
  • Infectious Disease
    • Hepatitis B Virus
    • Hepatitis C Virus
    • HIV
    • TB
    • Chlamydia Trachomatic and Neisseria Gonorrhea (CT/NG)
    • HPV
    • Methiciline Resistant Staphylococcus Aureus (MRSA)
    • Others
  • Myogenic Disorder
  • Clinical Diagnostic Confirmation
  • Prenatal Diagnostics
  • Pre-implantation Diagnostics
  • Others

MARKET BY END USERS

  • Point of Care
  • Diagnostic Center
  • Self Testing/OTC

MARKET BY GEOGRAPHY

  • North America
  • Asia Pacific
  • Europe
  • LAMEA
 

Chapter: 1 INTRODUCTION

1.1 Report Description
1.2 Reason for doing the study

1.2.1 Key Benefits
1.2.2 Key Market Segments
1.2.3 Key Audiences

1.3 Research Methodology

1.3.1 Secondary Research
1.3.2 Primary Research
1.3.3 Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1 CXO perspective
2.2 Market beyond what to expect by 2025 ($Million)

2.2.1 Moderate growth scenario
2.2.2 Rapid growth scenario
2.2.3 Diminishing growth scenario

Chapter: 3 MARKET OVERVIEW

3.1 Market Definition and Scope
3.2 Application of biotechnology in DNA Diagnostic
3.3 Responsibility of Next-generation Sequencing technologies
3.4 Key Findings

3.4.1 Top Factors Impacting on DNA Diagnostics market
3.4.2 Top Investment Pockets of DNA Diagnostics market
3.4.3 Top winning strategies of DNA Diagnostics market

3.5 Government Regulations

3.5.1 FDA guidelines for personalized medicines

3.6 P orters Five force Analysis

3.6.1 Bargaining power of suppliers
3.6.2 Bargaining power of Buyers
3.6.3 Threat from new entrants
3.6.4 Threat of Substitute
3.6.5 Competitive Rivalry

3.7 Value chain analysis

3.7.1 Primary Activities
3.7.2 Supportive activities

3.8 Clinical Trials
3.9 Patent Analysis

3.9.1 Patent analysis by geographies(2010-2014)
3.9.2 Patent analysis by sub-segment (2010-2014)

3.10 Market Share Analysis,2013
3.11 Market Dynamics

3.11.1 Drivers

3.11.1.1 Increasing incidences of chronic and infectious diseases
3.11.1.2 Technological Advancements and product modification
3.11.1.3 Increase in popularity personalized medicine approach

3.11.2 Restraints

3.11.2.1 High cost involved in reaseach & development
3.11.2.2 Unclear reimbursement policies&stringent government regulation

3.11.3 Opportunities

3.11.3.1 Technological Development
3.11.3.2 Increasing need of Personalized Medicines

Chapter: 4 GLOBAL DNA DIAGNOSTICS MARKET BY PRODUCT TYPES

4.1 Instruments

4.1.1 Key market trends
4.1.2 Competitive Scenario
4.1.3 Key growth factors and opportunities
4.1.4 Market size and forecast

4.2 Reagents

4.2.1 Key market trends
4.2.2 Competitive Scenario
4.2.1 Key growth factors and opportunities
4.2.2 Market size and forecast

4.3 Software & Services

4.3.1 Key market trends
4.3.1 Competitive Scenario
4.3.1 Key growth factors and opportunities
4.3.2 Market size and forecast

Chapter: 5 GLOBAL DNA DIAGNOSTICS MARKET BY TECHNOLOGY, 2013-2020

5.1 PCR

5.1.1 Key market trends
5.1.2 Competitive scenario
5.1.3 Key growth factors and opportunities
5.1.4 Market size and forecast

5.2 Microarrays

5.2.1 Lab on chip
5.2.2 DNA microarray
5.2.3 Protein microarray
5.2.4 Key market trends
5.2.5 Competitive scenario
5.2.6 Key growth factors and opportunities
5.2.7 Market size and forecast

5.3 In situ hybridization

5.3.1 Key market trends
5.3.2 Competitive scenario
5.3.3 Key growth factors and opportunities
5.3.4 Market size and forecast

5.4 Sequencing Technology

5.4.1 Key market trends
5.4.2 Competitive scenario
5.4.3 Key growth factors and opportunities
5.4.4 Market size and forecast

5.5 Mass Spectrometry

5.5.1 Key market trends
5.5.2 Competitive scenario
5.5.3 Key growth factors and opportunities
5.5.4 Market size and forecast

5.6 Others

5.6.1 Key market trends
5.6.2 Competitive scenario
5.6.3 Key growth factors and opportunities
5.6.4 Market size and forecast

Chapter: 6 GLOBAL DNA DIAGNOSTICS MARKET BY APPLICATIONS, 2013-2020

6.1 Oncology

6.1.1 Prostate Cancer
6.1.2 Breast Cancer
6.1.3 Colorectal Cancer
6.1.4 Others

6.2 Infectious disease testing

6.2.1 Hepatitis B Virus (HBV)
6.2.2 Hepatitis C Virus (HCV)
6.2.3 Human Immunodeficiency Virus (HIV)
6.2.4 Tuberculosis (TB)
6.2.5 Chlamydia Trachomatis and Neisseria Gonorrhoeae (CT/NG)
6.2.6 Human Papillomavirus (HPV)
6.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
6.2.8 Others

6.3 Myogenic disorder diagnosis
6.4 Clinical diagnosis confirmation
6.5 Prenatal diagnosis
6.6 Pre-implantation diagnosis
6.7 Others

Chapter: 7 GLOBAL DNA DIAGNOSTIC MARKET BY END-USERS, 2013-2020

7.1 Point of Care
7.2 Central Laboratories/Diagnostic Centers
7.3 Self Testing/OTC

Chapter: 8 GLOBAL DNA DIAGNOSTIC MARKET BY GEOGRAPHY, 2013-2020

8.1 North America

8.1.1 Key market trends
8.1.2 Competitive scenario
8.1.3 Key growth factors and opportunities
8.1.4 Market size and forecast
8.1.5 United States
8.1.6 Canada
8.1.7 Mexico

8.2 Europe

8.2.1 Key market trends
8.2.2 Competitive scenario
8.2.3 Key growth factors and opportunities
8.2.4 Market size and forecast
8.2.5 France
8.2.6 Germany
8.2.7 United Kingdom
8.2.8 Others

8.3 Asia-Pacific

8.3.1 Key market trends
8.3.2 Competitive scenario
8.3.3 Key growth factors and opportunities
8.3.4 Market size and forecast

8.4 LAMEA

8.4.1 Key market trends
8.4.2 Competitive scenario
8.4.3 Key growth factors and opportunities
8.4.4 Market size and forecast
8.4.5 Latin America
8.4.6 Middle East
8.4.7 Africa

Chapter: 9 ASIA PACIFIC DNA DIAGNOSTIC MARKET ANALYSIS 2013-2020

9.1 Market dynamics
9.2 Key market trends
9.3 Clinical trials
9.4 Government regulations
9.5 Company analysis by region

9.5.1 India

9.5.1.1 Genome Diagnostics Pvt. Ltd.
9.5.1.2 Transasia
9.5.1.3 Dr Reddys lab

9.5.2 china
9.5.3 Australia

9.5.3.1 Genera biosystems

9.5.4 Japan

9.5.4.1 Sysmex

Chapter: 10 COMPANY PROFILES

10.1 Sysmex

10.1.1 Company Overview
10.1.2 Company Snapshot
10.1.3 Financial performance
10.1.4Strategic moves and developments

10.1.4.1 Primary Strategy: product launch
10.1.4.2 secondary Strategy: collaboration and partnership

10.1.5SWOT analysis

10.2 Bayer Diagnostic

10.2.1 Overview
10.2.2 Company snapshot
10.2.3 Financial performance
10.2.4 Strategic moves and developments

10.2.4.1 Primary Strategy: product launch

10.2.5 SWOT analysis

10.3 Roche Diagnostics

10.3.1 Overview
10.3.2 Company snapshot
10.3.3 Financial performance
10.3.4 Strategic moves and developments

10.3.4.1 Primary Strategies:product launch
10.3.4.2 Secondary Strategy: Collaboration

10.3.5 SWOT analysis

10.4 Abbott Laboratories

10.4.1 Overview
10.4.2 Company snapshot
10.4.3 Financial performance
10.4.4 Strategic moves and developments

10.4.4.1 Primary Strategies: product launch

10.4.5 SWOT analysis

10.5 Cephide Inc.

10.5.1 Overview
10.5.2 Company snapshot
10.5.3 Financial performance
10.5.4 Strategic moves and developments

10.5.4.1 Primary Strategies: partnership and product launch
10.5.4.2 Secondary Strategy: Collaboration

10.5.5 SWOT analysis

10.6 Gen-probe Inc. (Hologic)

10.6.1 Overview
10.6.2 Company snapshot
10.6.3 Financial performance
10.6.4 Strategic moves and developments

10.6.4.1 Primary Strategy: product launch

10.6.5 SWOT analysis

10.7 Illumina, Inc.

10.7.1 Overview
10.7.2 Company snapshot
10.7.3 Financial performance
10.7.4 Strategic moves and developments

10.7.4.1 Primary Strategies: partnership and product launch

10.7.5 SWOT analysis

10.8 Thermo Fisher Scientific

10.8.1 Overview
10.8.2 Company snapshot
10.8.3 Financial performance
10.8.4 Strategic moves and developments

10.8.4.1 Primary Strategies:product launch
10.8.4.2 Secondary Strategy: Collaborationand acquisition

10.8.5 SWOT analysis

10.9 Bio-Rad Laboratories

10.9.1 Overview
10.9.2 Company snapshot
10.9.3 Financial performance
10.9.4 Strategic moves and developments

10.9.4.1 Primary Strategies: product launch
10.9.4.2 Secondary Strategies: Acquistaion

10.9.5 SWOT analysis

10.10 Johnson and Johnson

10.10.1 Overview
10.10.2 Company snapshot
10.10.3 Financial performance
10.10.4 Strategic moves and developments

10.10.4.1 Primary strategies: collaboration

10.10.5 SWOT analysis

10.11 Novartis

10.11.1 Overview
10.11.2 Company snapshot
10.11.3 Financial performance
10.11.4 Strategic moves and developments

10.11.4.1 Primary Strategies: product launch
10.11.4.2 secondary Strategies: collaboration and partnership

10.11.5 SWOT analysis

LIST OF TABLES

TABLE 1 Dna diagnostic market moderate growth scenario by geography, 2020-2025 ($Million)
TABLE 2 Dna diagnostic market rapid growth scenario by geography, 2020-2025 ($Million)
TABLE 3 Dna diagnostic market diminishing growth scenario by geography, 2020-2025 ($Million)
TABLE 4 Milestone of FDA guidelines for personalized medicines
TABLE 5 Clinical trials conducted for DNA diagnostics technologies
TABLE 6 Chronic Disease Prevalence
TABLE 7 Types of DNA diagnostic devices by technology
TABLE 8 Global dna diagnostic market revenue by product types, 2013-2020 ($Million)
TABLE 9 Global Instrument dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 10 Global reagents dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 11 Global software & services dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 12 Global dna diagnostic market revenue by technology 2013-2020 ($Million)
TABLE 13 Global PCR technology market revenue by geography: 2020-2025 ($Million)
TABLE 14 Microarray technology pricing chart
TABLE 15 Global Microarray technology market revenue by geography, 2013-2020 ($Million)
TABLE 16 In situ hybridization devices pricing chart
TABLE 17 Global In situ hybridization technology market revenue by geography, 2013-2020 ($Million)
TABLE 18 Global sequencing technology market revenue by market revenue by geography, 2013-2020 ($Million)
TABLE 19 laboratory equipment prices
TABLE 20 Global mass spectrometry market revenue by geography, 2013-2020 ($Million)
TABLE 21 Global other technology market revenue by geography, 2013-2020 ($Million)
TABLE 22 Global dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 23 Global oncology dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 24 Global Infectious diseases dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 25 Global Myogenic disorder dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 26 Global Clinical dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 27 Global Prenatal dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 28 Global Per-implantation dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 29 Other dna diagnostic application market revenue by geography, 2013-2020 ($Million)
TABLE 30 Global dna diagnostic market revenue by end users: 2013-2020 ($Million)
TABLE 31 Global point of care dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 32 Global diagnostic center dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 33 Global Self testing/OTC dna diagnostic market revenue by geography, 2013-2020 ($Million)
TABLE 34 United states dna diagnostics market revenue by application, 2013-2020 ($ million)
TABLE 35 Canada dna diagnostic market revenue by application, 2013-2020 ($ million)
TABLE 36 Mexico dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 37 France dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 38 Germany dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 39 United kingdom dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 40 Others dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 41 Asia pacific dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 42 lamea dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 43 LAtin america dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 44 Middle east dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 45 Africa dna diagnostic market revenue by application, 2013-2020 ($Million)
TABLE 46 Company snapshot of Sysmex
TABLE 47 Company snapshot of Bayer Diagnostic
TABLE 48 Company snapshot of Roche DIAGNOSTICS
TABLE 49 Company snapshot of Abbott Laboratories
TABLE 50 Company snapshot Cephide inc
TABLE 51 Company snapshot of Gen-probe Inc. (Hologic)
TABLE 52 Company snapshot of Illumina, Inc.
TABLE 53 Company snapshot of Thermo Fisher Scientific
TABLE 54 Company snapshot of Bio-Rad Laboratories
TABLE 55 Company snapshot of Johnson & Johnson
TABLE 56 Company snapshot of Novartis

LIST OF FIGURES

FIG.1 Top Factors Impacting on DNA Diagnostics market
FIG.2 Top Investment Pockets of DNA Diagnostics market
FIG.3 Top winning strategies for DNA diagnostic market during 2010-2014
FIG.4 Recent development of DNA diagnostic market by companies (2010-2014)
FIG.5 Top wining strategies by subtype of developments
FIG.6 Porters Five force Analysis of DNA DIagnostics market
FIG.7 Value chain analysis of Dna diagnostics market
FIG.8 Patent analysis by geographies (2010-2014)
FIG.9 Patent analysis of Sub Segment(2010-2014)
FIG.10 Market share analysis of DNA diagnostics market
FIG.11 Factors affecting the commercial potential of companies developing a molecular diagnostic
FIG.12 Net sales by geographic region (2013)
FIG.13 SWOT analysis of sysmex
FIG.14 Revenue generated
FIG.15 Revenue generation by segments
FIG.16 Swot analysis of Bayer
FIG.17 Net diagnostic sales by geography (2013)
FIG.18 SWOT analysis of roche Diagnostics
FIG.19 Net revenue generation by abbott (2012-2013)
FIG.20 Net revenue generation by segments (2013)
FIG.21 SWOT analysis of abbott LABORATORIES
FIG.22 Net sales by geography (2013)
FIG.23 Net sales by clinical and non clinical market(2013)
FIG.24 SWOT analysis of cepheid inc.
FIG.25 Revenue generated by the company in 2011 and 2012
FIG.26 SWOT analysis of Gen-probe Inc. (Hologic)
FIG.27 Net revenue generation (2012-2013)
FIG.28 SWOT analysis of ILLUMINA, INC.
FIG.29 Net sales by segments (2013)
FIG.30 Revenue generation (2011-2013)
FIG.31 Revenue genetaration by segments (2013)
FIG.32 Swot analysis of Thermo Fisher Scientific
FIG.33 Net revenue generation (2011-2013)
FIG.34 Net sales by segments (2013)
FIG.35 Net sales by geogrephy (2013)
FIG.36 SWOT analysis of bio-rad laboratories
FIG.37 Revenue generation by Segment (2013)
FIG.38 Revenues generation by Geography (2013)
FIG.39 SWOT analysis of johnson & johnson
FIG.40 Net revenue generation by geography (2013)
FIG.41 Net revenue generation by businesses (2013)
FIG.42 SWOT analysis of Novartis

 

The global DNA diagnostic market is expected to grow at healthy rate during the forecast period. The adoption of new technology such as next generation sequencing, polymerase chain reaction and microarray are primarily driving the DNA diagnostic market. The global DNA diagnostic market in this report is segmented based on the technology, application and end users.  Several diagnostic companies are exploiting the lucrative opportunities available in this market. DNA diagnostics is being used in several applications such as diagnosis of infectious diseases, oncology/cancer, myogenic disorders, prenatal diagnostics and pre-implantation diagnostics etc. The DNA diagnostics market has numerous opportunities in developed and developing economies due to increasing awareness amongst the public about healthcare, cost effective diagnostic solutions and accurate and faster test results. Demand for DNA diagnostic methods in developed economies would gain popularity in near future, as the consumer base in these countries shows an inclination towards effective diagnostic treatment instead of traditional medication; hence, the DNA diagnostic market is expecting sluggish growth in developed countries during the analysis period.

 

PURCHASE OPTIONS

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Reach out to us

Call us on
( U.S. - Canada toll free )
+1-800-792-5285,    Int'l : +1-503-894-6022
Drop us an email at
help@alliedmarketresearch.com

Send Enquiry
 

Request Sample

Request Customization

Request sample

OR

Purchase Full Report of
DNA Diagnostics Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020

  • Online Only
  • $4176
  • Online cloud Access only
  • Restricted Print, copy, paste,download
  • Read Only
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Data Pack
  • $4640
  • Restricted to one authorized users
  • One print only
  • Available in Excel
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Single User
  • $5540
  • Restricted to one authorized users
  • One print only
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Five User
  • $6654
  • Limited to 5 authorized users
  • Print Upto Five Copies
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In
  • Enterprise
    License/PDF

  • $9280
  • Unlimited within company/enterprise
  • Unlimited within company/enterprise
  • Available in Excel & PDF
  • 20% free customization (Pre-Sale)
  •   Free quartery industry update
  •   Free report update (Within 180 days)
  •   Subscription Model Sign In

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 
 

FREQUENTLY ASKED
QUESTIONS?

 
 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 
 
 

Why Allied Market Research

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 
 

Featured Readings

 

Get Fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Access reports on all emerging
market of Life Sciences on Knowledge Tree Platform
Free Demo